# Progress Note 05 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: John Henry Holliday (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI007-SYN-TD
- Date: 1873-05-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Martin Beaumont, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Nausea, vomiting, and loose stools for two days during tuberculosis treatment. **S**

## History of present illness

Mr. Holliday is a 21-year-old dentist with drug-susceptible cavitary pulmonary tuberculosis in the sixth week of the continuation phase of isoniazid and rifampin, given by video-observed therapy, and with a mild alcohol use disorder. Two days ago he developed nausea and loose stools, and he vomited twice yesterday; two coworkers at the dental office had a stomach illness last week. When he reported the nausea on his video call this morning, the health department nurse told him to hold today's doses, as his treatment plan instructs, and to be seen today with liver tests. He has no yellowing of the eyes or skin, no dark urine or pale stools, no pain under the right ribs, and no itching or rash. His cough has gone and he has had no fevers or night sweats. He has not missed any other dose. He told us that nine days ago, at a friend's birthday party, he drank about six whiskeys over an evening, the first time he has drunk heavily since starting treatment; he has not drunk since. He feels he let himself down but has no thoughts of suicide. **S**

| Element | Detail |
|---|---|
| Onset | Two days ago |
| Location | Upper abdomen and bowel |
| Duration | Two days |
| Character | Nausea, two vomits, and loose stools |
| Severity | Mild to moderate; drinking fluids |
| Timing | Sixth week of the continuation phase |
| Context | Coworkers with a stomach illness; one evening of heavy drinking nine days ago |
| Modifying factors | Today's doses held on the nurse's advice |
| Associated signs and symptoms | No jaundice, dark urine, right upper abdominal pain, rash, or fever |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired with the illness; no fever or night sweats |
| Eyes | Negative | No yellowing of the eyes; vision normal |
| Respiratory | Negative | No cough, sputum, or breathlessness |
| Gastrointestinal | Positive | Nausea, two vomits yesterday, and loose stools; no right upper abdominal pain, blood, or pale stools |
| Genitourinary | Negative | Urine orange from rifampin as expected, not dark brown |
| Integumentary | Negative | No jaundice, rash, or itching |
| Neurological | Negative | No numbness or tingling of the hands or feet |
| Psychiatric | Negative | Disappointed about the party; no thoughts of suicide or self-harm |

8 systems reviewed. **S**

## Current medications

- Isoniazid 300 mg tablet, one tablet daily **S**
- Rifampin 300 mg capsules, two capsules (600 mg) daily **S**
- Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 108/68 mmHg; pulse 98 bpm; respirations 16/min; temperature 37.4 °C; oxygen saturation 98% on room air; weight 61.8 kg; BMI 19.5 kg/m². All vital signs are synthetic.

ALT: 64 U/L (high); AST: 58 U/L (high); Total bilirubin: 0.9 mg/dL; Alkaline phosphatase: 98 U/L; AUDIT-C: 4. All results are synthetic.

## Change since baseline

- ALT: 34 U/L at baseline, 64 U/L (high) at this visit **S**
- AST: 38 U/L at baseline, 58 U/L (high) at this visit **S**
- Total bilirubin: 0.6 mg/dL at baseline, 0.9 mg/dL at this visit **S**
- Alkaline phosphatase: 92 U/L at baseline, 98 U/L at this visit **S**
- AUDIT-C: 9 at baseline, 4 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Tired but well-appearing; weight 61.8 kg, down 0.7 kg from the last visit |
| Eyes | No scleral icterus |
| Mouth | Mucous membranes slightly dry |
| Respiratory | Clear; a few fine crackles at the right apex that clear with coughing |
| Abdomen | Soft, mildly tender around the umbilicus; liver not enlarged or tender; no guarding |
| Skin | No jaundice or rash |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute viral gastroenteritis** (A08.4). A short illness shared with coworkers, with loose stools, no fever, and a benign abdomen. ALT 64 and AST 58 U/L are only just above normal, with normal bilirubin 0.9 and alkaline phosphatase 98. Drug-induced liver injury is defined as ALT at least three times the upper limit with symptoms, or five times without; ALT here is about 1.1 times the upper limit, so this is not drug-induced liver injury. The small rise fits the recent heavy drinking and the viral illness. **S**
   - Oral fluids and a bland diet; no antiemetic needed now.
   - Hand washing; stay off work until two days after the symptoms stop.
2. **Pulmonary tuberculosis, continuation phase** (A15.0). Clinically well on treatment, with no cough or fever. One day's doses held today. **S**
   - Resume isoniazid and rifampin tomorrow under video-observed therapy once he can keep food down; the missed dose is added at the end, so the last dose moves one day later.
   - Repeat liver tests in two weeks.
   - Stop the doses and call the same day for yellow eyes or skin, dark urine, right upper abdominal pain, or vomiting that returns.
3. **Alcohol use disorder, mild, with one lapse** (F10.10). One evening of heavy drinking after more than two months with little or none. AUDIT-C 4. A lapse he has reported openly. Safety reviewed: no thoughts of suicide; the 988 Suicide & Crisis Lifeline is in his phone. **S**
   - Brief counseling today about the extra liver risk from alcohol on isoniazid; he recommits to no alcohol until treatment ends.
   - Plan for parties: arrive with a non-alcoholic drink and leave early, and tell one friend his goal.
   - Next session with his substance-use counselor this week.

## Guideline basis

- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016), American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America (Clinical Infectious Diseases)
- An official ATS statement: hepatotoxicity of antituberculosis therapy (2006), American Thoracic Society (American Journal of Respiratory and Critical Care Medicine)
- VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), United States Department of Veterans Affairs and Department of Defense
- 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea (2017), Infectious Diseases Society of America (Clinical Infectious Diseases)

## Follow-up

- Health department nurse to confirm the restart on tomorrow's video call. Liver tests in two weeks. End-of-treatment visit in the summer. **S**
- Next scheduled visit 1873-08-18: end-of-treatment review after six months. **S**
